United States Biotechnology & Medical Research

Provectus Biopharmaceuticals Inc (PVCT)

Track

Track

Provectus Biopharmaceuticals Inc has recorded no insider trading activity within the last ninety days. The most recent transactions occurred on December 14, 2017, when John R. Glass executed two separate purchases of company shares. Historical records indicate earlier divestment patterns by other individuals, but current market participation remains inactive.
Ticker: PVCT Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Glass John R See Remarks
Transaction date
Purchase
Price
125.91
Quantity 77,064 +18.7%
Value US$283,906
Glass John R See Remarks
Transaction date
Purchase
Price
16.97
Quantity 67,536 +27.8%
Value US$1,574,457
ADAMS DONALD E Large shareholder
Transaction date
Sale
Price
359.93
Quantity 5,424 +23.8%
Value US$4,201,901
ADAMS DONALD E Large shareholder
Transaction date
Sale
Price
2.90
Quantity 5,000 -0.1%
Value US$14,500
ADAMS DONALD E Large shareholder
Transaction date
Sale
Price
2.89
Quantity 5,000 -0.1%
Value US$14,450
ADAMS DONALD E Large shareholder
Transaction date
Sale
Price
2.99
Quantity 5,000 -0.1%
Value US$14,950
ADAMS DONALD E Large shareholder
Transaction date
Sale
Price
2.86
Quantity 5,000 -0.1%
Value US$14,300
ADAMS DONALD E Large shareholder
Transaction date
Sale
Price
2.80
Quantity 50,000 -0.9%
Value US$140,000
ADAMS DONALD E Large shareholder
Transaction date
Sale
Price
2.40
Quantity 25,000 -0.4%
Value US$60,000
ADAMS DONALD E Large shareholder
Transaction date
Sale
Price
2.08
Quantity 20,000 -0.4%
Value US$41,500
ADAMS DONALD E Large shareholder
Transaction date
Sale
Price
1.45
Quantity 630 -0.0%
Value US$914
ADAMS DONALD E Large shareholder
Transaction date
Sale
Price
1.47
Quantity 4,000 -0.1%
Value US$5,880
ADAMS DONALD E Large shareholder
Transaction date
Sale
Price
1.29
Quantity 2,000 -0.0%
Value US$2,580
ADAMS DONALD E Large shareholder
Transaction date
Sale
Price
1.24
Quantity 2,000 -0.0%
Value US$2,480
ADAMS DONALD E Large shareholder
Transaction date
Sale
Price
1.15
Quantity 4,000 -0.1%
Value US$4,600
ADAMS DONALD E Large shareholder
Transaction date
Sale
Price
1.14
Quantity 2,000 -0.0%
Value US$2,280
ADAMS DONALD E Large shareholder
Transaction date
Sale
Price
1.14
Quantity 2,000 -0.0%
Value US$2,280
ADAMS DONALD E Large shareholder
Transaction date
Sale
Price
1.13
Quantity 2,000 -0.0%
Value US$2,260
ADAMS DONALD E Large shareholder
Transaction date
Sale
Price
1.12
Quantity 8,000 -0.1%
Value US$8,960
ADAMS DONALD E Large shareholder
Transaction date
Sale
Price
1.15
Quantity 4,772 -0.1%
Value US$5,488
ADAMS DONALD E Large shareholder
Transaction date
Sale
Price
1.13
Quantity 4,000 -0.1%
Value US$4,520
ADAMS DONALD E Large shareholder
Transaction date
Sale
Price
1.17
Quantity 2,000 -0.0%
Value US$2,340
ADAMS DONALD E Large shareholder
Transaction date
Purchase
Price
1.05
Quantity 679,048 +13.6%
Value US$713,000
ADAMS DONALD E Large shareholder
Transaction date
Sale
Price
1.20
Quantity 1,500 -0.0%
Value US$1,800
ADAMS DONALD E Large shareholder
Transaction date
Sale
Price
1.20
Quantity 6,000 -0.1%
Value US$7,200
ADAMS DONALD E Large shareholder
Transaction date
Sale
Price
1.23
Quantity 2,000 -0.0%
Value US$2,460
ADAMS DONALD E Large shareholder
Transaction date
Sale
Price
1.22
Quantity 6,000 -0.1%
Value US$7,320
ADAMS DONALD E Large shareholder
Transaction date
Sale
Price
1.13
Quantity 15,000 -0.3%
Value US$16,950
ADAMS DONALD E Large shareholder
Transaction date
Purchase
Price
1.54
Quantity 20,000 +0.3%
Value US$30,800
ADAMS DONALD E Large shareholder
Transaction date
Purchase
Price
1.60
Quantity 20,000 +0.3%
Value US$32,000
WACHTER ERIC PHD Vice President Pharmaceuticals Executive Director
Transaction date
Purchase
Price
0.75
Quantity 264,705 +18.8%
Value US$198,529
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2017-12-18 2017-12-14 B Purchase Glass John R

See Remarks
77,064 +18.7%
125.91
US$283,906 		77,064 +18.7% 125.91 US$283,906
2017-12-18 2017-12-14 B Purchase Glass John R

See Remarks
67,536 +27.8%
16.97
US$1,574,457 		67,536 +27.8% 16.97 US$1,574,457
2007-09-24 2007-09-22 S Sale ADAMS DONALD E Large shareholder
5,424 +23.8%
359.93
US$4,201,901 		5,424 +23.8% 359.93 US$4,201,901
2007-09-24 2007-09-06 S Sale ADAMS DONALD E Large shareholder
5,000 -0.1%
2.90
US$14,500 		5,000 -0.1% 2.90 US$14,500
2007-09-24 2007-09-06 S Sale ADAMS DONALD E Large shareholder
5,000 -0.1%
2.89
US$14,450 		5,000 -0.1% 2.89 US$14,450
2007-09-24 2007-09-06 S Sale ADAMS DONALD E Large shareholder
5,000 -0.1%
2.99
US$14,950 		5,000 -0.1% 2.99 US$14,950
2007-09-24 2007-09-06 S Sale ADAMS DONALD E Large shareholder
5,000 -0.1%
2.86
US$14,300 		5,000 -0.1% 2.86 US$14,300
2007-09-24 2007-09-06 S Sale ADAMS DONALD E Large shareholder
50,000 -0.9%
2.80
US$140,000 		50,000 -0.9% 2.80 US$140,000
2007-09-24 2007-09-05 S Sale ADAMS DONALD E Large shareholder
25,000 -0.4%
2.40
US$60,000 		25,000 -0.4% 2.40 US$60,000
2007-09-24 2007-09-04 S Sale ADAMS DONALD E Large shareholder
20,000 -0.4%
2.08
US$41,500 		20,000 -0.4% 2.08 US$41,500
2007-09-24 2007-04-11 S Sale ADAMS DONALD E Large shareholder
630 -0.0%
1.45
US$914 		630 -0.0% 1.45 US$914
2007-09-24 2007-04-03 S Sale ADAMS DONALD E Large shareholder
4,000 -0.1%
1.47
US$5,880 		4,000 -0.1% 1.47 US$5,880
2007-09-24 2007-03-21 S Sale ADAMS DONALD E Large shareholder
2,000 -0.0%
1.29
US$2,580 		2,000 -0.0% 1.29 US$2,580
2007-09-24 2007-03-19 S Sale ADAMS DONALD E Large shareholder
2,000 -0.0%
1.24
US$2,480 		2,000 -0.0% 1.24 US$2,480
2007-09-24 2007-03-07 S Sale ADAMS DONALD E Large shareholder
4,000 -0.1%
1.15
US$4,600 		4,000 -0.1% 1.15 US$4,600
2007-09-24 2007-03-02 S Sale ADAMS DONALD E Large shareholder
2,000 -0.0%
1.14
US$2,280 		2,000 -0.0% 1.14 US$2,280
2007-09-24 2007-02-23 S Sale ADAMS DONALD E Large shareholder
2,000 -0.0%
1.14
US$2,280 		2,000 -0.0% 1.14 US$2,280
2007-09-24 2007-02-20 S Sale ADAMS DONALD E Large shareholder
2,000 -0.0%
1.13
US$2,260 		2,000 -0.0% 1.13 US$2,260
2007-09-24 2007-02-13 S Sale ADAMS DONALD E Large shareholder
8,000 -0.1%
1.12
US$8,960 		8,000 -0.1% 1.12 US$8,960
2007-09-24 2007-02-07 S Sale ADAMS DONALD E Large shareholder
4,772 -0.1%
1.15
US$5,488 		4,772 -0.1% 1.15 US$5,488
2007-09-24 2007-02-06 S Sale ADAMS DONALD E Large shareholder
4,000 -0.1%
1.13
US$4,520 		4,000 -0.1% 1.13 US$4,520
2007-09-24 2007-01-31 S Sale ADAMS DONALD E Large shareholder
2,000 -0.0%
1.17
US$2,340 		2,000 -0.0% 1.17 US$2,340
2007-09-24 2007-01-27 B Purchase ADAMS DONALD E Large shareholder
679,048 +13.6%
1.05
US$713,000 		679,048 +13.6% 1.05 US$713,000
2007-09-24 2007-01-24 S Sale ADAMS DONALD E Large shareholder
1,500 -0.0%
1.20
US$1,800 		1,500 -0.0% 1.20 US$1,800
2007-09-24 2007-01-22 S Sale ADAMS DONALD E Large shareholder
6,000 -0.1%
1.20
US$7,200 		6,000 -0.1% 1.20 US$7,200
2007-09-24 2007-01-17 S Sale ADAMS DONALD E Large shareholder
2,000 -0.0%
1.23
US$2,460 		2,000 -0.0% 1.23 US$2,460
2007-09-24 2007-01-16 S Sale ADAMS DONALD E Large shareholder
6,000 -0.1%
1.22
US$7,320 		6,000 -0.1% 1.22 US$7,320
2007-09-24 2006-08-11 S Sale ADAMS DONALD E Large shareholder
15,000 -0.3%
1.13
US$16,950 		15,000 -0.3% 1.13 US$16,950
2006-05-31 2006-05-24 B Purchase ADAMS DONALD E Large shareholder
20,000 +0.3%
1.54
US$30,800 		20,000 +0.3% 1.54 US$30,800
2006-05-31 2006-05-24 B Purchase ADAMS DONALD E Large shareholder
20,000 +0.3%
1.60
US$32,000 		20,000 +0.3% 1.60 US$32,000
2005-12-12 2005-12-09 B Purchase WACHTER ERIC PHD

Vice President Pharmaceuticals

Executive Director
264,705 +18.8%
0.75
US$198,529 		264,705 +18.8% 0.75 US$198,529
Explore more

More insider trading research around Provectus Biopharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America